Erythromycin C

Erythromycin C is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 35291 references associated with Erythromycin C in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Erythromycin C

Download all related citations
Per page 10 20 50 100 | Total 7634
Authors Title Published Journal PubMed Link
Kohyama T et al. Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. 1999 Antimicrob. Agents Chemother. pmid:10103198
Moss AA et al. Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. 1978 AJR Am J Roentgenol pmid:101028
Provencher SJ et al. Effect of cyclosporine A on cytochrome P-450-mediated drug metabolism in the partially hepatectomized rat. 1999 Drug Metab. Dispos. pmid:10101139
Neaverson MA Intravenous administration of erythromycin: serum, sputum and urine levels. 1976 Curr Med Res Opin pmid:1009781
Gates PJ et al. Structural elucidation studies of erythromycins by electrospray tandem mass spectrometry. 1999 Rapid Commun. Mass Spectrom. pmid:10097401
Baron GS and Nano FE An erythromycin resistance cassette and mini-transposon for constructing transcriptional fusions to cat. 1999 Gene pmid:10095104
Nieuwenhuijs VB et al. The effects of ABT-229 and octreotide on interdigestive small bowel motility, bacterial overgrowth and bacterial translocation in rats. 1999 Eur. J. Clin. Invest. pmid:10092986
Sunazuka T et al. Effects of erythromycin and its derivatives on interleukin-8 release by human bronchial epithelial cell line BEAS-2B cells. 1999 J. Antibiot. pmid:10092202
Stacey A and Bradlow A Arcanobacterium haemolyticum and Mycoplasma pneumoniae co-infection. 1999 J. Infect. pmid:10090506
Suzuki H et al. Inhibitory effect of erythromycin on interleukin-8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis. 1999 Laryngoscope pmid:10089966
Zweers-Zeilmaker WM et al. In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle. 1999 Res. Vet. Sci. pmid:10088712
Clark MJ et al. Erythromycin derivatives ABT 229 and GM 611 act on motilin receptors in the rabbit duodenum. 1999 Clin. Exp. Pharmacol. Physiol. pmid:10081621
DiBaise JK and Quigley EM Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience. 1999 J. Clin. Gastroenterol. pmid:10078820
Periti P and Mazzei T Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. 1999 J Chemother pmid:10078776
Collard JM et al. Erythromycin enhances early postoperative contractility of the denervated whole stomach as an esophageal substitute. 1999 Ann. Surg. pmid:10077045
Cline MS et al. Bacillary angiomatosis in a renal transplant recipient. 1999 Transplantation pmid:10075597
Hsueh PR et al. Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. 1999 J. Clin. Microbiol. pmid:10074498
Manna PK and Basu SK Studies of erythromycin maltobionate, a new derivative of erythromycin. 1999 Drug Dev Ind Pharm pmid:10071836
Nielsen J The role of metabolic engineering in the production of secondary metabolites. 1998 Curr. Opin. Microbiol. pmid:10066494
Dordick JS et al. The evolution of biotransformation technologies. 1998 Curr. Opin. Microbiol. pmid:10066492
Tsang KW et al. A pilot study of low-dose erythromycin in bronchiectasis. 1999 Eur. Respir. J. pmid:10065682
Furness JB et al. An action of erythromycin in the intestine that is not mediated via motilin receptors. 1999 Clin. Exp. Pharmacol. Physiol. pmid:10065328
Gump DW and Hawley HB Severe Mycoplasma pneumoniae pneumonia. 1976 Respiration pmid:1005941
Miyajima M et al. Effects of erythromycin on experimental extrinsic allergic alveolitis. 1999 Clin. Exp. Allergy pmid:10051731
McDaniel R et al. Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel "unnatural" natural products. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10051557
Wubbel L et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. 1999 Pediatr. Infect. Dis. J. pmid:10048679
Anandatheerthavarada HK et al. Physiological role of the N-terminal processed P4501A1 targeted to mitochondria in erythromycin metabolism and reversal of erythromycin-mediated inhibition of mitochondrial protein synthesis. 1999 J. Biol. Chem. pmid:10037757
Rediske AM et al. Reducing bacterial resistance to antibiotics with ultrasound. 1999 Lett. Appl. Microbiol. pmid:10030038
Hirsch R et al. Occurrence of antibiotics in the aquatic environment. 1999 Sci. Total Environ. pmid:10028708
Xiong L et al. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre. 1999 Mol. Microbiol. pmid:10027979
Hansen LH et al. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. 1999 Mol. Microbiol. pmid:10027978
Nissan A et al. A direct inhibitory effect of erythromycin on rat urinary bladder smooth muscle. 1999 J. Urol. pmid:10022741
Tomomasa T et al. Gastrointestinal sounds and migrating motor complex in fasted humans. 1999 Am. J. Gastroenterol. pmid:10022632
pmid:

Table of Content